We have previously shown that the level of FKBP52 proteins is strongly reduced in the frontal cortex of patients affected with AD and FTLD-Tau (frontotemporal lobar degeneration with Tau pathology) (Giustiniani et al., 2012). The gene discussed is MAPT; the disease is Alzheimer disease.